These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 6541921)

  • 1. [Pharmacokinetics of a fluoride-calcium preparation for the treatment of osteoporosis].
    Fuchs C; Haase W; Maurer H
    Arzneimittelforschung; 1984; 34(7):832-5. PubMed ID: 6541921
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Combined fluoride/calcium therapy of osteoporosis].
    Krokowski E
    Fortschr Med; 1984 Nov; 102(41):1067-70. PubMed ID: 6500471
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Multiple-dose pharmacokinetics of paracetamol and salicylamide in man after combined rectal application (author's transl)].
    Liedtke R; Ebel S; Missler B; Haase W; Stein L
    Arzneimittelforschung; 1980; 30(8):1295-8. PubMed ID: 7192145
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fluoride pharmacokinetics: its implications in the fluoride treatment of osteoporosis.
    Ekstrand J; Spak CJ
    J Bone Miner Res; 1990 Mar; 5 Suppl 1():S53-61. PubMed ID: 2339637
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bioavailability and pharmacokinetic characteristics of two monofluorophosphate preparations with calcium supplement.
    Setnikar I; Rovati LC; Schmid K; Vens-Cappell B; Barkworth MF
    Arzneimittelforschung; 1998 Dec; 48(12):1172-8. PubMed ID: 9893933
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Comparative pharmacokinetics of paracetamol in humans following single oral and rectal administration (author's transl)].
    Liedtke R; Berner G; Haase W; Nicolai W; Staab R; Wagener HH
    Arzneimittelforschung; 1979; 29(10):1607-11. PubMed ID: 583229
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Comparison of the bioavailability of fluoride after the administration of sodium fluoride alone or combined with calcium].
    Briancon D; Quillet P; Duplan B; Chapuy MC; Arlot M; Meunier PJ
    Therapie; 1988; 43(2):107-10. PubMed ID: 3406928
    [No Abstract]   [Full Text] [Related]  

  • 8. A physiologically based pharmacokinetic model for fluoride uptake by bone.
    Rao HV; Beliles RP; Whitford GM; Turner CH
    Regul Toxicol Pharmacol; 1995 Aug; 22(1):30-42. PubMed ID: 7494900
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Combined fluoride therapy for primary osteoporosis. Results of two-years' treatment with sodium monofluorophosphate and calcium].
    Ringe JD
    Fortschr Med; 1987 Jun; 105(19):379-82. PubMed ID: 3623388
    [No Abstract]   [Full Text] [Related]  

  • 10. Single-dose pharmacokinetics of macrocrystalline nitrofurantoin formulations.
    Liedtke RK; Ebel S; Missler B; Haase W; Stein L
    Arzneimittelforschung; 1980; 30(5):833-6. PubMed ID: 7190430
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Comparison of the fluoride bioavailability from two oral preparations of monofluorophosphate disodium in combination with various calcium salts].
    Brazier M; Fardelonne P; Bellony R; Sebert JL; Desmet G; Hary L; Richard MO
    Therapie; 1990; 45(3):235-41. PubMed ID: 2363111
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A phase I, randomized, open-label, crossover study of the single-dose pharmacokinetic properties of guanfacine extended-release 1-, 2-, and 4-mg tablets in healthy adults.
    Swearingen D; Pennick M; Shojaei A; Lyne A; Fiske K
    Clin Ther; 2007 Apr; 29(4):617-25. PubMed ID: 17617285
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparing the efficacy in providing instant relief of dentin hypersensitivity of a new toothpaste containing 8.0% arginine, calcium carbonate, and 1450 ppm fluoride to a benchmark desensitizing toothpaste containing 2% potassium ion and 1450 ppm fluoride, and to a control toothpaste with 1450 ppm fluoride: a three-day clinical study in Mississauga, Canada.
    Ayad F; Ayad N; Delgado E; Zhang YP; DeVizio W; Cummins D; Mateo LR
    J Clin Dent; 2009; 20(4):115-22. PubMed ID: 19831164
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetic profile of talipexole in healthy volunteers is not altered when it is co-administered with Madopar (co-beneldopa).
    Zhang TT; Song M; Hang TJ; Xu XF; Wen AD; Yang L; Jia L
    J Clin Pharm Ther; 2009 Jun; 34(3):345-54. PubMed ID: 19646081
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Fluoride treatment of osteoporosis].
    Schulz W
    Wien Med Wochenschr; 2000; 150(3):42-52. PubMed ID: 10756596
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of calcium from calcium supplements in healthy volunteers.
    Nowak MG; Szulc-MusioĊ‚ B; Ryszka F
    Pak J Pharm Sci; 2008 Apr; 21(2):109-12. PubMed ID: 18390439
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thalidomide does not alter estrogen-progesterone hormone single dose pharmacokinetics.
    Scheffler MR; Colburn W; Kook KA; Thomas SD
    Clin Pharmacol Ther; 1999 May; 65(5):483-90. PubMed ID: 10340913
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bioavailability and pharmacokinetics of fluoride from two glutamine monofluorophosphate preparations.
    Warneke G; Setnikar I
    Arzneimittelforschung; 1993 May; 43(5):584-90. PubMed ID: 8329004
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Blood pharmacokinetics of fluorine in man after the oral administration of nicomethanol hydrofluoride].
    Cheymol G; Souleau M; Mahuzier G; Poitou P
    J Biol Buccale; 1984 Dec; 12(4):349-53. PubMed ID: 6597190
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetic properties of combination oxycodone plus racemic ibuprofen: two randomized, open-label, crossover studies in healthy adult volunteers.
    Kapil R; Nolting A; Roy P; Fiske W; Benedek I; Abramowitz W
    Clin Ther; 2004 Dec; 26(12):2015-25. PubMed ID: 15823765
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.